← Back to Entity Graph

Charlie Teo Foundation

Concentration Risk
FoundationRegistryHPCABN 57622041061NSW
Relationships
23
Data Sources
2
Revenue
$3.8M
Total Outbound
$500K
Preview
Data as of: 19 June 2026
Found in 2 systems—ACNC CharitiesFoundations

Board Interlocks (2 shared directors)

Shaun Treacyalso sits on
Multiple Sclerosis AustraliaMultiple Sclerosis Queensland LtdMultiple Sclerosis Research Australia LimitedPROJECT DIGNITY LTD
Kerry-Anne Johnstonalso sits on
Bayard Foundation

Giving Philosophy

The foundation is committed to funding cutting-edge, innovative research that promises significant breakthroughs in understanding, diagnosing, and treating brain tumours and cancer. It seeks out pioneering projects globally, valuing scientific advancement and potentially collaborative efforts to achieve its health objectives.

Wealth Source:Corporate foundation

Tips for Applicants

Prospective applicants should demonstrate how their project contributes to pioneering research in brain tumours or cancer, focusing on innovative diagnostic or therapeutic approaches. Highlight potential for significant breakthroughs and broad impact.

Programs & Opportunities (3)

Research Rebels
grant · research, health ·
$200K

Supporting unconventional, innovative approaches to brain cancer treatment

Better Tools
grant · research, health ·
$200K

Developing better models, tools, and methodologies for brain cancer research and treatment testing

More Data
grant · research, health ·
$100K

Data-driven research projects targeting adult diffuse gliomas, GBM, and childhood brain cancers

Notable Grants

  • $1.65M to Prof Matt Dun (University of Newcastle) for I-DIMENSIONS subtyping system for DMG/DIPG
  • $1.2M to Prof Joseph Powell (Garvan Institute) for Cancer Genomics
  • $1.09M to Prof Peter Fecci (Duke University) for Unshackling the Immune System 2.0
  • $1.08M to Prof Joseph Powell (Garvan Institute) for Targeting the Root of Adult Diffuse Gliomas
  • $714K to A/Prof Hong Chen (Washington University) for Nasal Drug Delivery to Brainstem for DIPG/DMG
  • $609K to Prof Roel Verhaak (Jackson Laboratory) for Evolution of Childhood Brain Cancer
  • $595K to Prof Gelareh Zadeh (Mayo Clinic) for Unmasking Hypoxia in GBM
  • $477K to Prof Peter Fecci (Duke University) for Unshackling the Immune System

Financial History (5 years)

YearRevenueExpensesAssetsSurplus
2023$3.8M$2.9M$10.6M$895K
2022$3.6M$2.9M$9.7M$634K
2021$3.8M$2.6M$9.4M$1.2M
2020$3.0M$2.8M$7.8M$217K
2019$8.5M$992K$7.8M$7.5M
0
Grants Given (AU)
$1.3M
Staff (FTE)
4
Volunteers
50
Donations Received
$2.7M

Community Evidence

External Evidence

Identity

GS ID
AU-ABN-57622041061
ABN
57622041061
Sector
health
Financial Year
2023

Focus Areas

Themes
health
Geography
AU-National
Target Recipients
communityyouthaged
Purposes
Health
Beneficiaries
AdultsAgedChildrenEarly ChildhoodFamiliesGeneral CommunityOtherYouth

Board & Leadership (6)

Financials

Revenue
$3.8M
Assets
$10.6M

Method

Match Confidence
registry
Cross-references
2 datasets
Match Key
ABN
Relationships
23

Matched by Australian Business Number (ABN) — high confidence. This entity was found across multiple government datasets using the same ABN.

Data Sources

ACNCFoundations

JusticeHub

External Link

This entity is also tracked in JusticeHub with 0 interventions and 0 evidence records.

External ecosystem profile linked from GrantScope for additional context. JusticeHub content is maintained separately.

View on JusticeHub

Location Intelligence

Postcode
2011
Locality
Potts Point - Woolloomooloo
Remoteness
Major Cities of Australia
SEIFA Disadvantage
Decile 8/10
LGA
Sydney
SA2 Region
Potts Point - Woolloomooloo
Entities in Area
327
View on Power Map